Retina Biomarkers for Treatment Selection in DME

Epidemiology, disease burden, and current treatment options.

By Kailynn M. Barton, BS, Muhammad Abidi, BS, Rajiv M. Sastry, BA, et al.

AI Screening for Diabetic Retinopathy

Head-to-head validation studies and emerging equity metrics are refining how these systems are evaluated and deployed.

By Abraham Olvera-Barrios, MD, PhD, Cathy Egan, FRANZCO

New Strategies for Managing Diabetic Retinopathy

Advances in therapy and technology are extending durability and enabling individualized management of DR.

By Omar Saeed, MPH, Veeral S. Sheth, MD, MBA, FACS

Steroid Strategies in Diabetic Macular Edema

Patient selection, dosing strategies, and practical considerations for incorporating corticosteroids into clinical practice.

By Ashish Sharma, MD, Baruch D. Kuppermann, MD, PhD

Telemedicine and Retina Care

Lessons in access, equity, and efficiency.

By Nnamdi Elem Okore, OD

Update on Diabetic Disease

Upfront: The May/June issue has a focus on diabetic retinal disease.

By Diana V. Do, MD

PRIMA Implant Shows Clinical Potential

Clinical Trial Download: Early PRIMAvera trial data suggest that subretinal photovoltaic implantation is a viable approach to restoring central vision in GA.

By Frank Brodie, MD, MBA, Nitish Mehta, MD, Yasha Modi, MD

Diabetes Mellitus Coding in Retina

Coding Q&A: Accurate ICD-10 coding for diabetic eye disease depends on clearly documenting diabetes type, retinopathy severity, macular edema status, and laterality.

By Elizabeth Cifers, MBA, MSW, CHC, CPC

Clinical Trial Update May/June 2026

Access Retinal Physician's listing of all active clinical trials in AMD, DME, RVO, and uveitis.

Video: Artificial Intelligence Dominates ARVO Retina Sessions

Nearly half of the retina program is related to artificial intelligence, according to ARVO program co-chair Amitha Domalpally, MD, PhD. Other areas of interest include real-world anti-VEGF data and regenerative medicine.

By Amitha Domalpally, MD, PhD